BioNTech SE - ADR

BNTX

Market Cap$21.93B

Close$

Compare BioNTech SE

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
BioNTech SE - ADR	21.3	0%	5%	5.4	-
Market Avg	58.2	1.29%	31%	-	1
Healthcare Avg	64	1.3%	15%	-	0.9

$118.75

Target Price by Analysts

28.7% upsideBioNTech SE Target Price Details

$-68.26

Current Fair Value

174% downside

Overvalued by 174% based on the discounted cash flow analysis.

Share Statistics

Market cap	$21.93 Billion
Enterprise Value	$9.28 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$4.24
Beta	0.47
Outstanding Shares	237,725,735
Avg 30 Day Volume	588,256

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	21.32
PEG	-26.91
Price to Sales	5.43
Price to Book Ratio	0.98
Enterprise Value to Revenue	2.2
Enterprise Value to EBIT	9.68
Enterprise Value to Net Income	9
Total Debt to Enterprise	0.03
Debt to Equity	0.01

Revenue Sources

No data

ESG Score

No data

About BioNTech SE